Follow
Marc-Andre Fortin
Title
Cited by
Cited by
Year
Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning
MA Fortin, RM Petoral, F Söderlind, A Klasson, M Engström, T Veres, ...
Nanotechnology 18 (39), 395501, 2007
2192007
Synthesis and Characterization of Tb3+-Doped Gd2O3 Nanocrystals: A Bifunctional Material with Combined Fluorescent Labeling and MRI Contrast Agent …
RM Petoral Jr, F Soderlind, A Klasson, A Suska, MA Fortin, N Abrikossova, ...
The Journal of Physical Chemistry C 113 (17), 6913-6920, 2009
1992009
Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI
L Faucher, M Tremblay, J Lagueux, Y Gossuin, MA Fortin
ACS applied materials & interfaces 4 (9), 4506-4515, 2012
1672012
Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity
M Bouchoucha, MF Cote, R C.-Gaudreault, MA Fortin, F Kleitz
Chemistry of Materials 28 (12), 4243-4258, 2016
1472016
US Hospitalizations for Malignant PleuraláEffusions: Data From the 2012 National Inpatient Sample
N Taghizadeh, M Fortin, A Tremblay
Chest 151 (4), 845-854, 2017
1412017
Ultra‐small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI
L Faucher, AA Guay‐Bégin, J Lagueux, MF Côté, E Petitclerc, MA Fortin
Contrast media & molecular imaging 6 (4), 209-218, 2011
1332011
Gold nanoparticles in radiotherapy and recent progress in nanobrachytherapy
M Laprise‐Pelletier, T Simăo, MA Fortin
Advanced healthcare materials 7 (16), 1701460, 2018
982018
Enhanced Relaxometric Properties of MRI “Positive” Contrast Agents Confined in Three‐Dimensional Cubic Mesoporous Silica Nanoparticles
R Guillet‐Nicolas, JL Bridot, Y Seo, MA Fortin, F Kleitz
Advanced Functional Materials 21 (24), 4653-4662, 2011
882011
Mesoporous silica nanoparticles: selective surface functionalization for optimal relaxometric and drug loading performances
M Bouchoucha, R C.‐Gaudreault, MA Fortin, F Kleitz
Advanced Functional Materials 24 (37), 5911-5923, 2014
862014
Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles
L Faucher, Y Gossuin, A Hocq, MA Fortin
Nanotechnology 22 (29), 295103, 2011
832011
High Relaxivities and Strong Vascular Signal Enhancement for NaGdF4 Nanoparticles Designed for Dual MR/Optical Imaging
R Naccache, P Chevallier, J Lagueux, Y Gossuin, S Laurent, ...
Advanced Healthcare Materials 2 (11), 1478-1488, 2013
812013
Multidentate block-copolymer-stabilized ultrasmall superparamagnetic iron oxide nanoparticles with enhanced colloidal stability for magnetic resonance imaging
N Chan, M Laprise-Pelletier, P Chevallier, A Bianchi, MA Fortin, JK Oh
Biomacromolecules 15 (6), 2146-2156, 2014
732014
Approach to hemoptysis in the modern era
S Gagnon, N Quigley, H Dutau, A Delage, M Fortin
Canadian respiratory journal 2017, 2017
722017
Surface modification of gadolinium oxide thin films and nanoparticles using poly (ethylene glycol)-phosphate
AA Guay-Bégin, P Chevallier, L Faucher, S Turgeon, MA Fortin
Langmuir 28 (1), 774-782, 2012
612012
Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies
R Guillet-Nicolas, M Laprise-Pelletier, MM Nair, P Chevallier, J Lagueux, ...
Nanoscale 5 (23), 11499-11511, 2013
592013
Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging
P Chevallier, A Walter, A Garofalo, I Veksler, J Lagueux, S Bégin-Colin, ...
Journal of Materials Chemistry B 2 (13), 1779-1790, 2014
552014
MnO-labeled cells: positive contrast enhancement in MRI
M Létourneau, M Tremblay, L Faucher, D Rojas, P Chevallier, Y Gossuin, ...
The journal of physical chemistry B 116 (44), 13228-13238, 2012
552012
Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting
M Bouchoucha, É Béliveau, F Kleitz, F Calon, MA Fortin
Journal of materials chemistry B 5 (37), 7721-7735, 2017
522017
Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2: 342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma
MA Fortin, A Orlova, PU Malmström, V Tolmachev
International journal of molecular medicine 19 (2), 285-291, 2007
472007
Colloidal synthesis and characterization of ultrasmall perovskite GdFeO3 nanocrystals
F Söderlind, MA Fortin, RM Petoral, A Klasson, T Veres, M Engström, ...
Nanotechnology 19 (8), 085608, 2008
462008
The system can't perform the operation now. Try again later.
Articles 1–20